Dr. Constantinos Zamboglou
Dr. Zamboglou studied medicine in Freiburg, Germany. In this period, he completed his doctoral thesis at the laboratory of Prof. Aktories (Institute of Pharmacology). In 2019 he obtained his board license and in 2020 his postdoctoral lecture qualification. From 2019-2020 he worked as senior consultant, where he was responsible for the treatment of prostate cancer patients. In 2021 he also became the section head of the department of interventional radiotherapy. Since 2021 he is an invited member of the German prostate cancer expert panel and member of the ESTRO-ACROP guideline committee for prostate cancer. He has published over 90 research articles in renowned and peer-reviewed journals, and he is first or last author in 5 scientific publications with IF>10.
Prof. Triantafyllos Stylianopoulos
Prof. Stylianopoulos is an Associate Professor of Mechanical Engineering and Head of the Cancer Biophysics Lab at UCY. His publication record includes over 150 peer-reviewed articles (h-index: 59, >20,600 citations, GoogleScholar) in the fields of cancer research, bioengineering and drug delivery. In recognition of his work, he has received a Starting and a Consolidator Grant by the European Research Council, the prestigious Y.C. Fung Early Career award by the American Society of Mechanical Engineers (2016) for excellence in Bioengineering, as well as awards from the US Biomedical Engineering Society-BMES and the Research and Innovation Foundation of Cyprus. His research involves the development of mathematical models for cancer using systems biology and machine learning methods as well as extensive experimental research in preclinical and in vitro tumor models. In 2024, Prof. Stylianopoulos received the UNESCO-Equatorial Guinea International Prize for Research in Life Sciences.
Dr. Pantelis Georgiades
Dr Pantelis Georgiades holds a Masters In Physics and PhD in biological physics from the University of Manchester. After the completion of his PhD studies in 2014, he was employed at the University of Manchester as a post-doctoral research associate in the field of super-resolution microscopy. Later, he was employed at Odyssey Cybersecurity Consultants as a data scientist, in the R&D department. There, he developed bespoke network anomaly detection algorithms and User and Entity behaviour analysis models, using novel machine learning and deep methodologies. After this, he was employed at CyI as a Postdoctoral Research Fellow in the field of Vector borne diseases, where he investigated the population dynamics and the epidemiology of VBDs through mathematical and machine learning methods, as well as assessing the impact of climate change to them. He was later promoted to the rank of Associate Research Scientist at the institute and his research interests revolve around using novel AI methodologies in climate science, health and the impacts of climate change. Dr Georgiades has authored numerous scientific publications and presented in international conferences and has received over 450 citations.
Prof. Andreas Charalambous
Prof. Charalambous is a Professor for Oncology and Palliative Care at the CUT and an Adjunct at the University of Turku in Finland. He is the founder and Past-President of the Cyprus Oncology Nursing Society, Past-President of the European Oncology Nursing Society (EONS) and Immediate Past-President of the European Cancer Organization. He is also the Founder of the Cancer Nursing Fund. He holds an extensive expertise in testing and implementing innovations in clinical practice alongside testing their feasibility and effectiveness. He has published over 200 National and International publications in esteem journals.
Dr. Ioanna Pelagia
Dr. Pelagia is the Head of Statistics at ClinBAY, holding a BSc in Mathematics, MSc in Statistics and PhD in Statistics, all from the University of Manchester. Her main area of interest is Statistics in Medicine, having completed both her MSc and PhD degrees in collaboration with the Department of Medicine of the University of Manchester, developing variable selection based on Cox Proportional Hazard models including random terms based on breast cancer, kidney patients and type 2 diabetics data. She joined ClinBAY right after graduating in 2016, and has experience as Study Statistician and Line Manager of over 150 clinical trials and survival analysis, involved in Phase I and II trials in respiratory, pediatric, ophthalmology, nephropathy, oncology, cardiovascular etc. She has also worked as a part-time lecturer at the European University of Cyprus, teaching Biostatistics and Statistics modules.
Georgina Kyriakoudes
Kyriakoudes is the CEO and co-founder of Dcentric Health (Aria) and an ACCA chartered accountant holding a MSc in Digital Currency from the University of Nicosia. She was one of the first people in the world to gain a Masters in Blockchain with distinction in 2018. Prior to co-founding Dcentric Health she spent 10 years working in international businesses in London and Cyprus as an auditor, including PwC and Deloitte. She gained her Certified Accountant qualification and built successful online education platforms. Thanks to her extensive research into medical records and blockchain, she has been published in prestigious publications such as the Lancet and has delivered keynote speeches across the world. Georgina is also the Cyprus representative of the European Female Founders Forum, set up by the European Commission, assisting in promoting gender equality in entrepreneurship and business.
Prof. Panagiotis Papageorgis
Prof. Panagiotis Papageorgis is a Professor of Molecular Biology and the Dean of the School of Sciences at European University Cyprus. He is also the Director of the Basic and Translational Cancer Research Center (BTCRC) and the Head of the Tumor Microenvironment, Metastasis and Experimental Therapeutics Research Group. His research interests include the elucidation of the molecular mechanisms in regulating metastatic cancer progression. He is also developing various methodologies, using animal tumor models and scRNA sequencing analysis to decipher the role of tumor microenvironment (TME) components and combinatorial drug treatments to improve the efficacy of cancer immunotherapy.
Dr. Marianna Prokopi Demetriades
Dr. Prokopi is a post-doctoral fellow and a well-established biotech innovator in Cyprus. Sie is the Co-founder of three local companies:Theramir Ltd., RAL Revolutionary Labs Ltd. and Promed Bioscience. In the last years, she has won several distinguished awards for her contributions to the healthcare and innovation sector in Cyprus (Cyprus Research Award 2021, GWTA Founder Award 2022, King’s Distinguished Alumni STEM Award 2022).
Dr. Alexander Thieme
Dr. Thieme is a board-certified radiation oncologist and computer scientist. He is the author of the “open-source personalized recommendation system” (OSPRS) that collects patient symptom data and incorporates machine learning algorithms for personalized patient guidance in different fields of medicine (infectious diseases and oncology). The system has already been used by millions of users for patient guidance and has been featured in Nature Medicine.
